PBK
CARM

Peoples Bank (Kansas)’s Carisma Therapeutics CARM Stock Holding History

Peoples Bank (Kansas)’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250
Closed -$77 – 149
2025
Q1 		$77 Hold
250
– – ﹤0.01% 330
2024
Q4 		$102 Hold
250
– – ﹤0.01% 315
2024
Q3 		$245 Hold
250
– – ﹤0.01% 313
2024
Q2 		$377 Hold
250
– – ﹤0.01% 265
2024
Q1 		$565 Hold
250
– – ﹤0.01% 261
2023
Q4 		$732 Hold
250
– – ﹤0.01% 256
2023
Q3 		$1.06K Buy
+250
New +$1.58K ﹤0.01% 251

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Peoples Bank (Kansas)'s CARM Position: Q2 2025 in Review

Peoples Bank (Kansas) sold out of Carisma Therapeutics (CARM) in Q2 2025, closing a stake of 250 shares — an estimated $77 sold.

Peoples Bank (Kansas) first reported a position in CARM in Q3 2023 and held it in 7 quarters. The position peaked at $1.06K in Q3 2023. 36 funds tracked by Wall St. Rank hold CARM as of Q2 2025.

  • Peoples Bank (Kansas) reported no remaining Carisma Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Peoples Bank (Kansas) sold 250 Carisma Therapeutics shares in Q2 2025, an estimated $77.
  • Peoples Bank (Kansas) first reported a position in Carisma Therapeutics in Q3 2023 and held it in 7 quarters.
  • Peoples Bank (Kansas)'s Carisma Therapeutics position peaked at $1.06K in Q3 2023.
  • 36 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2025.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2025, filed 10 Jul 2025.